HELPTAG:MemberSignIn

May 17, 2010

Member Sign In:
Latest in Home
Breast Cancer
FES-PET guides second-line therapy decisions in breast cancer
September 18, 2026
Fda Button 400
Recalls stable for radiation oncology tools despite tech advancements
September 18, 2026
Free webinar for radiology leaders
Sponsored
Free webinar for radiology leaders
September 17, 2026
Radiation oncology medical physicist Michael Grams, MD, holds a device called a tungsten collimator that divides a conventional radiation beam into submillimeter-wide beamlets.
Minibeam radiotherapy performs well in first clinical trial
September 17, 2026
More in Home
FES-PET guides second-line therapy decisions in breast cancer
By Will Morton
FES-PET/CT results led to therapeutic management changes in 37.8% of patients.
September 18, 2026
Breast Cancer
Recalls stable for radiation oncology tools despite tech advancements
By Amerigo Allegretto
While radiation oncology devices using AI or machine learning are increasingly entering the market, recalls may be plateauing.
September 18, 2026
Fda Button 400
Ultrasound MinnieCast, Episode 17: Elastography holds promise toward expanded role
By Amerigo Allegretto
David Fetzer, MD, discusses current applications and issues in the world of elastography.
September 18, 2026
Minnie Cast Thumbnail (25)
Minibeam radiotherapy performs well in first clinical trial
By Will Morton
The technique delivers very high doses of radiation through closely spaced, extremely narrow beams.
September 17, 2026
Radiation oncology medical physicist Michael Grams, MD, holds a device called a tungsten collimator that divides a conventional radiation beam into submillimeter-wide beamlets.
USPSTF names radiologist to task force; ACR responds
By Amerigo Allegretto
Dennis Wulfeck, MD, has 33 years of experience in diagnostic imaging, and his appointment to the task force has the support of the ACR.
September 17, 2026
Capitol Hill Government 400
Individual specialization may drive IR procedure complexity
By Amerigo Allegretto
Practice- and radiologist-level IR specializations showed associations with greater procedural complexity.
September 17, 2026
Interventional Radiology 400
AI boosts brain aneurysm detection on CT angiography
By Will Morton
AI preferentially detected smaller aneurysms (< 3 mm), while radiologists more often identified larger aneurysms (3 to 5 mm and > 5 mm).
September 17, 2026
Ai Brain
ASTRO issues first radiation therapy guideline for bladder cancer
By AuntMinnie.com staff writers
Bladder preservation should be presented as a curative treatment option alongside radical cystectomy.
September 16, 2026
Astro1
LLM on par with head-and-neck subspecialists in analyzing MRI reports
By Amerigo Allegretto
GPT-5-Thinking yields similar diagnostic accuracy compared to subspecialists focusing on orbital and head-and-neck MRI.
September 16, 2026
Mri Brain Head 400
CCTA links neighborhood income to atherosclerosis
By Will Morton
The relationship between socioeconomic disparities and imaging-defined coronary atherosclerosis on CCTA has not been fully understood.
September 15, 2026
Heart 1
Chest CT muscle attenuation predicts future bone density loss
By Will Morton
Muscle and bone loss commonly coexist with aging, but potential links between paraspinal muscle and thoracic vertebral bone mineral density loss remain poorly understood
September 15, 2026
Study overview. (A) Volumetric segmentation of the paraspinal musculature was performed for 1,316 participants. (B) Manual segmentation was performed, the results were compared with the volumetric segmentation results, and the Dice score and the intersection over union were calculated. (C) The three-dimensional segmentations from T1 through T10 were individually extracted and combined into a single volume for analyses. (D) Muscle volume and median muscle attenuation were derived from the segmentation volumes. (E) Analyses were performed to assess the correlation of the paraspinal muscle attenuation and volume with the bone mineral density and the ability to predict vertebral fractures. NIFTI = Neuroimaging Informatics Technology Initiative, 3D = three-dimensional.
Curium gets FDA approval for Lu-177 injection for GEP-NETs
By AuntMinnie.com staff writers
The radioligand therapy delivers targeted radiation to GEP-NETs by binding to somatostatin receptors expressed on these tumors.
September 15, 2026
Approved Stamp 400
Page 1 of 250
Next Page